IL6 and COVID-19: Several studies have documented significant elevation in inflammatory cytokines (IFN-γ, TNF-α, IL-6) in severe COVID-19 compared to non-severe cases [3, 7–9] that are consistent with this study and may be proposed as prognostic markers.